JAMES STROUSE: Open Payments
NPI 1649950809 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,189 in 62 payments from 14 companies in 2025. Trend: 2023 $183 · 2024 $1,974 · 2025 $1,189
Food & beverage: $1,189
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $266 |
| Supernus Pharmaceuticals, Inc. | 14 | $175 |
| Corium, LLC | 6 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $113 |
| Janssen Pharmaceuticals, Inc | 4 | $109 |
| Tris Pharma Inc | 5 | $97 |
| Alkermes, Inc. | 3 | $64 |
| ABBVIE INC. | 2 | $57 |
| Almatica Pharma LLC | 3 | $57 |
| Noven Therapeutics, LLC | 3 | $53 |
Products named: Auvelity, Qelbree, Azstarys, TRINTELLIX, SPRAVATO, Dyanavel XR, VRAYLAR, LOREEV XR.
Industry payments across FL — which companies pay providers there.
